Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial

Diseases of the Esophagus

Volumn 18, Issue 3, 2005, Pages 131-139

  Bergquist, H ^a   Wenger, U ^b   Johnsson, E ^a   Nyman, J ^a   Ejnell, H ^a   Hammerlid, E ^a   Lundell, L ^a,c   Ruth, M ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Department of Surgery ^*  (Sweden)

Author keywords

Brachytherapy; Esophageal neoplasms; Palliative care; Quality of life; Stents

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPHAGIA; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STENT; SURVIVAL TIME;

EID: 29144449888     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2005.00467.x     Document Type: Article

References (33)

1. Siersema P D, Dees J, van Blankenstein M. Palliation of inalignant dysphagia from oesophageal cancer. Scand J Gastroenterol 1998; 33: 75-84.
2. Frenken M. Best palliation in esophageal cancer: surgery, stenting, radiation, or what? Dis Esophagus 2001; 14: 120-3.
3. Weigel T L, Frumiento C, Gaumintz E. Endoluminal palliation for dysphagia secondary to esophageal carcinoma. Surg Clin North Am 2002; 82: 747-61.
4. Aaronson N K, Ahmedzai S, Bergman B et al. The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-76.
5. Blazeby J M, Conroy T, Hammerlid E et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 2003; 39: 1384-94.
6. Siersema P D, Marcon N, Vakil N. Metal stents for tumors of the distal esophagus and gastric cardia. Endoscopy 2003; 35: 79-85.
7. Dormann A, Meisner S, Verin N, Wenk Lang A. Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy 2004; 36: 543-50.
8. Homs M Y, Eijkenboom W, Coen V et al. High dose rate brachytherapy for the palliation of malignant dysphagia. Radiother Oncol 2003; 66: 327-32.
9. Sur R K, Levin C V, Donde B, Sharma V, Miszczyk L, Nag S. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma - an International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys 2002; 53: 127-33.
10. Shasha D, Harrison L B. The role of brachytherapy for palliation. Semin Radiat Oncol 2000; 10: 222-39.
11. Jager J, Langendijk H, Pannebakker M, Rijken J, de Jong J. A single session of intraluminal brachytherapy in palliation of oesophageal cancer. Radiother Oncol 1995; 37: 237-40.
12. Spencer G M, Thorpe S M, Blackman G M et al. Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: a randomised study. Gut 2002; 50: 224-7.
13. Ilson D H. Oesophageal cancer: new developments in systemic therapy. Cancer Treat Rev 2003; 29: 525-32.
14. Homs M Y, Essink-Bot M L, Borsboom G J, Steyerberg E W, Siersema P D, Dutch SIREC Study Group. Quality of life after palliative treatment for oesophageal carcinoma - a prospective comparison between stent placement and single dose brachytherapy. Eur J Cancer 2004; 40: 1862-71.
15. Ogilvie A L, Dronfield M W, Ferguson R, Atkinson M. Palliative intubation of oesophagogastric neoplasms at fibre-optic endoscopy. Gut 1982; 23: 1060-7.
16. Gaspar L E, Nag S, Herskovic A, Mantravadi R, Speiser B. American Brachytherapy Society Consensus Guidelines for brachytherapy of esophageal cancer. Int J Radiat Oncol Biol Phys 1997; 38: 127-32.
17. Schag C C, Heinrich R L, Ganz P A. Karnofsky performance status revisited: Reliability, validity, and guidelines. J Clin Oncol 1984; 2: 187-93.
18. Fayers P M, Aaronson N K, Bjordal K, Curran D, Groenvold M. on behalf of EORTC Quality of Life Study Group. EORTC QLQ-C30 Scoring Manual, 2nd edn. Brussels: EORTC 1997.
19. Blazeby J M, Alderson D, Winstone K et al. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality Life Study Group. Eur J Cancer 1996; 32A: 1912-17.
20. Zigmond A S, Snaith R P. The Hospital Anxiety and Depression scale. Acta Psychiat Scand 1983; 67: 361-70.
21. Good P. Permutation tests. A practical guide to resampling methods for testing hypotheses. New York: Springer Inc 2000: 36-7, 51-2.
22. King M T. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 1996; 5: 555-67.
23. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16: 139-44.
24. Svedlund J, Sullivan M, Sjodin I, Liedman B, Lundell L. Quality of life in gastric cancer prior to gastrectomy. Qual Life Res 1996; 5: 255-64.
25. Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001; 37: 1345-51.
26. Hammerlid E, Bjordal K, Ahlner-Elmqvist M et al. A prospective study of quality of life in head and neck cancer patients. Part I: at diagnosis. Laryngoscope 2001; 111: 669-80.
27. Hammerlid E, Ahlner-Elmqvist M, Bjordal K et al. A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients. Br J Cancer 1999; 80: 766-74.
28. Knyrim K, Wagner H J, Bethge N, Keymling M, Vakil N. A controlled trial of an expandable metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 1993; 329: 1302-7.
29. Vakil N, Morris A I, Marcon N et al. A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol 2001; 96: 1791-6.
30. Siersema P D, Hop W C, van Blankenstein M et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 2001; 54: 145-53.
31. Walther C, Zilling T, Perfekt R, Moller T. Increasing prevalence of adenocarcinoma of the oesophagus and gastrooesophageal junction: a study of the Swedish population between 1970 and 1997. Eur J Surg 2001; 167: 748-57.
32. Spinelli P, Cerrai F G, Ciuffi M, Ignomirelli O, Meroni E, Pizzetti P. Endoscopic stent placement for cancer of the lower esophagus and gastric cardia. Gastrointest Endosc 1994: 40: 455-7.
33. Suntharalingam M, Moughan J, Coia L R et al. 1996-1999 Patterns of Care Study. The national practice for patients receiving radiation therapy for carcinoma of the esophagus: results of the 1996-1999 Patterns of Care Study. Int J Radiat Oncol Biol Phys 2003; 56: 981-7.